Nu‑Tek BioSciences will use BioProcess International East to argue that raw‑material choices—specifically animal‑origin‑free peptones and hydrolysates—matter for media consistency, supply continuity, and downstream process robustness in biologics manufacturing.
Nu‑Tek is promoting 100% animal‑origin‑free peptones and protein hydrolysates aimed at improving media consistency and reducing raw‑material risk for cell culture and microbial fermentation.
The company will use BPI East to discuss product performance, qualification of critical raw materials, and a variability reduction program tied to supply continuity and traceability.
Nu‑Tek operates a dedicated manufacturing facility for animal‑origin‑free peptones and hydrolysates and positions these materials as a way to simplify sourcing and regulatory concerns related to animal‑derived components.
Image generated with Google Gemini As biopharmaceutical manufacturers push for tighter process control and more resilient supply chains, raw materials used in cell-culture media are receiving closer scrutiny. Nu-Tek BioSciences is bringing that conversation to BioProcess International East (BPI East) in Boston, where the company will highlight its portfolio of 100% animal-origin-free peptones and protein hydrolysates. The Minnetonka, MN-based supplier says its plant- and yeast-derived nutrients are intended for cell culture and microbial fermentation applications supporting vaccines, therapeutics, and other biologics.
During the meeting, Nu-Tek also plans to discuss its variability reduction program with teams looking to improve media consistency. The company also operates a purpose-built manufacturing facility dedicated to animal-origin-free peptones and protein hydrolysates. For Nu-Tek, BPI East is less about introducing a single new product than about making the case that raw-material strategy has become a competitive part of bioprocess design.
Today, food processors face the dual challenge of achieving sustainability goals and guaranteeing product safety.
Say you're building a new electrolyte powder, collagen gummy, or energy chew. Your spec calls for eight vitamins, three minerals, a stabilized botanical extract, and a sweetener blend that won't clash with your flavor system. Nearly every ingredient comes from a different supplier, each with its own lead time, minimum
Surface materials rarely attract serious supply chain attention until something goes wrong. A shipment arrives with visible colour deviation across panels. A worktop that passed factory inspection begins delaminating six months into service. A bulk order specified as high-performance HPL turns out, under testing, to be
Supply chain risk management has moved from a theoretical discipline to an operational imperative over the past several years. The disruptions that cascaded through global supply chains — from manufacturing shutdowns and shipping bottlenecks to raw material shortages and geopolitical trade tensions — have forced su
Spectroscopic analysis techniques rely on empirical models that are time consuming and expensive to make. Biopharma companies could speed development and reduce costs using a model-free measuring approach called pure-component analysis, says Nirrin Technologies. The post Model-Free, Pure Component Analysis Could Help B
Process intensification and the adoption of continuous-mode manufacturing has increased the consumption of culture media. Managing these ever-growing culture volumes in a cost and space efficient manner has become a major challenge for drug manufacturers, says Just – Evotec Biologics. The post Intense Media Pressure an
Loading more related stories...
Open the app view to save this story, compare related coverage, and continue from the same source.